Rates of Cognitive Decline in 100 Patients With Alzheimer Disease

REFERENCES

1. 1.↵
   Alzheimer's Association. 2018 Alzheimer's disease facts and figures. Alzheimers Dement. 2018;14(3):367-429. doi: 10.1016/j.jalz.2018.02.001. Erratum in: Alzheimers Dement. 2018;14(5):701. doi: 10.1016/j.jalz.2018.04.001

   OpenUrlCrossRef
2. 2.↵
   1. Bullido MJ,
   2. Guallar-Castillón P,
   3. Artiga MJ,
   4. et al.

   Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender. Neurosci Lett. 2000;289(3):213-216. doi: 10.1016/s0304-3940(00)01304-5

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Panza F,
   2. D'Introno A,
   3. Colacicco AM

   , et al. Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 polymorphism in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2004;126B(1):69-73. doi: 10.1002/ajmg.b.20146

   OpenUrlCrossRef
4. 4.↵
   1. Han L,
   2. Cole M,
   3. Bellavance F,
   4. McCusker J,
   5. Primeau F

   . Tracking cognitive decline in Alzheimer's disease using the Mini-Mental State Examination: a meta-analysis. Int Psychogeriatr. 2000;12(2):231-247. doi: 10.1017/s1041610200006359

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Clark CM,
   2. Sheppard L,
   3. Fillenbaum GG,
   4. et al.

   Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol. 1999;56(7):857-862. doi: 10.1001/archneur.56.7.857

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Sanz C,
   2. Andrieu S,
   3. Sinclair A,
   4. Hanaire H,
   5. Vellas B

   , REAL.FR Study Group. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology. 2009;73(17):1359-1366. doi: 10.1212/WNL.0b013e3181bd80e9

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Roselli F,
   2. Tartaglione B,
   3. Federico F,
   4. Lepore V,
   5. Defazio G,
   6. Livrea P

   . Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors. Clin Neurol Neurosurg. 2009;111(4):327-330. doi: 10.1016/j.clineuro.2008.10.006

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Pike CJ

   . Sex and the development of Alzheimer's disease. J Neurosci Res. 2017;95(1-2):671-680. doi: 10.1002/jnr.23827

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Altmann A,
   2. Tian L,
   3. Henderson VW,
   4. Greicius MD

   , Alzheimer's Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75(4):563-573. doi: 10.1002/ana.24135

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Engler-Chiurazzi EB,
    2. Brown CM,
    3. Povroznik JM,
    4. Simpkins JW

    . Estrogens as neuroprotectants: estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol. 2017;157:188-211. doi: 10.1016/j.pneurobio.2015.12.008

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Rajan KB,
    2. McAninch EA,
    3. Wilson RS,
    4. Weuve J,
    5. Barnes LL,
    6. Evans DA

    . Race, APOEε4, and long-term cognitive trajectories in a biracial population sample. J Alzheimers Dis. 2019; 72(1):45-53. doi: 10.3233/JAD-190538

    OpenUrlCrossRef
12. 12.↵
    1. Bienias JL,
    2. Beckett LA,
    3. Bennett DA,
    4. Wilson RS,
    5. Evans DA

    . Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis. 2003;5(5):349-355. doi: 10.3233/jad-2003-5501

    OpenUrlCrossRef
13. 13.↵
    1. Zhao Q,
    2. Zhou B,
    3. Ding D,
    4. et al.

    Cognitive decline in patients with Alzheimer's disease and its related factors in a memory clinic setting, Shanghai, China. PLoS One. 2014;9(4):e95755. doi: 10.1371/journal.pone.0095755

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Hsiao YH,
    2. Chang CH,
    3. Gean PW

    . Impact of social relationships on Alzheimer's memory impairment: mechanistic studies. J Biomed Sci. 2018;25(1):3. doi: 10.1186/s12929-018-0404-x

    OpenUrlCrossRef
15. 15.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR

    . "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198. doi: 10.1016/0022-3956(75)90026-6

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Nasreddine ZS,
    2. Phillips NA,
    3. Bédirian V,
    4. et al.

    The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. doi: 10.1111/j.1532-5415.2005.53221.x. Erratum in: J Am Geriatr Soc. 2019;67(9):1991. doi: 10.1111/jgs.15925

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Roalf DR,
    2. Moberg PJ,
    3. Xie SX,
    4. Wolk DA,
    5. Moelter ST,
    6. Arnold SE

    . Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2013;9(5):529-537. doi: 10.1016/j.jalz.2012.10.001

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Cataldo JK,
    2. Prochaska JJ,
    3. Glantz SA

    . Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis. 2010;19(2):465-480. doi: 10.3233/JAD-2010-1240

    OpenUrlCrossRef
19. 19.↵
    1. Peters R,
    2. Poulter R,
    3. Warner J,
    4. Beckett N,
    5. Burch L,
    6. Bulpitt C

    . Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 2008;8:36. doi: 10.1186/1471-2318-8-36

    OpenUrlCrossRefPubMed